Statins recommended for persons with HIV with a 10-year ASCVD risk score of 5% or higher; favored for those with risk score <5%.

Patients with diabetic kidney disease (DKD) and anemia have no worse, and possibly better, cardiovascular outcomes from finerenone treatment.

Dr. Marty Makary, head of the U.S. Food and Drug Administration (FDA), said Wednesday that the decision should be made between a pregnant woman and her doctor. “The data on the COVID vaccine booster ...

Sepsis-associated CVD mortality increased in the United States after the start of the COVID-19 pandemic, with the highest rates observed in older adults and Black patients.